铜负载葡萄糖氧化酶纳米药物用于肝癌的化学动力学治疗
The Copper-Loaded Glucose Oxidase Nanomedicines for Chemodynamic Therapy of Hepatocellular Carcinoma
摘要: 目的:为了达到靶向肿瘤部位实现肝癌的精准治疗,设计合成一种负载葡萄糖氧化酶(GOx)和铜离子(Cu2 )的纳米药物(Cu@GoxNM),通过化学动力学治疗达到对肿瘤细胞的杀伤作用。方法:通过“一锅法”合成铜负载葡萄糖氧化酶的纳米药物,通过扫描电镜和元素映射检测相关元素来验证纳米药物的合成。验证该纳米药物的级联催化产生活性氧作用。通过MTT细胞毒活实验,细胞活性氧的检测和活死细胞染色实验来验证其对细胞的影响,由此来证明化学动力学治疗的效果。结果:成功合成了铜负载葡萄糖氧化酶的纳米药物Cu@GoxNM;Cu@GoxNM对HUH7细胞的促凋亡作用与其浓度呈正相关;与对照细胞相比Cu@GoxNM致HUH7细胞产生更多的活性氧并发生细胞凋亡。结论:Cu@GoxNM纳米药物能明显促进肝癌细胞的凋亡,其是通过产生过量的活性氧达到化学动力学疗法作用。
Abstract: Objective: In order to achieve precise treatment of liver cancer by targeting the tumour site, to design and synthesize a nanomedicine (Cu@GoxNM) loaded with glucose oxidase (GOx) and copper ions (Cu2 ), which can kill the tumour cells through chemodynamic therapy. Methods: Synthesis of copper-loaded glucose oxidase nanomedicine by “one-pot method” was demonstrated by scanning electron microscopy (SEM) and elemental mapping for the detection of relevant elements. The cascade-catalyzed generation of reactive oxygen species by the nanomedicine was experimentally verified. The effects of the nanomedicine on cells were verified by MTT cytotoxicity assay, cellular reactive oxygen species assay, and staining assay of live and dead cells to demonstrate the effectiveness of chemodynamic therapy. Results: The copper-loaded glucose oxidase nanomedicine Cu@GoxNM was successfully synthesised; the pro-apoptotic effect of Cu@GoxNM on HUH7 cells was positively correlated with its concentration; Cu@GoxNM resulted in the production of more reactive oxygen species and apoptosis in HUH7 cells compared to control cells. Conclusion: Cu@GoxNM nanomedicine significantly promotes the apoptosis of hepatocellular carcinoma cells, and it might be the effect of chemodynamic therapy by generating excessive reactive oxygen species.
文章引用:吴婷婷, 郝希伟. 铜负载葡萄糖氧化酶纳米药物用于肝癌的化学动力学治疗[J]. 临床医学进展, 2024, 14(4): 1063-1070. https://doi.org/10.12677/acm.2024.1441126

参考文献

[1] Vogel, A., Meyer, T., Sapisochin, G., et al. (2022) Hepatocellular Carcinoma. The Lancet, 400, 1345-1362. [Google Scholar] [CrossRef
[2] Forner, A., Gilabert, M., Bruix, J., et al. (2014) Treatment of Intermediate-Stage Hepatocellular Carcinoma. Nature Reviews Clinical Oncology, 11, 525-535. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, C., Zhang, Y.B. and Dong, Y.Z. (2021) Lipid Nanoparticle-MRNA Formulations for Therapeutic Applications. Accounts of Chemical Research, 54, 4283-4293. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, M.-L., John, M., Lee, S.L., et al. (2017) Development Considerations for Nanocrystal Drug Products. The AAPS Journal, 19, 642-651. [Google Scholar] [CrossRef] [PubMed]
[5] Maeda, H. (2001) The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: The Key Role of Tumor-Selective Macromolecular Drug Targeting. Advances in Enzyme Regulation, 41, 189-207. [Google Scholar] [CrossRef
[6] Maeda, H. (2017) Polymer Therapeutics and the EPR Effect. Journal of Drug Targeting, 25, 781-785. [Google Scholar] [CrossRef
[7] Zhou, Q., Dong, C.Y., Fan, W.F., et al. (2020) Tumor Extravasation and Infiltration as Barriers of Nanomedicine for High Efficacy: The Current Status and Transcytosis Strategy. Biomaterials, 240, Article ID: 119902. [Google Scholar] [CrossRef] [PubMed]
[8] Kim, B.-E., Nevitt, T. and Thiele, D.J. (2008) Mechanisms for Copper Acquisition, Distribution and Regulation. Nature Chemical Biology, 4, 176-185. [Google Scholar] [CrossRef] [PubMed]
[9] Lutsenko, S. (2010) Human Copper Homeostasis: A Network of Interconnected Pathways. Current Opinion in Chemical Biology, 14, 211-217. [Google Scholar] [CrossRef] [PubMed]
[10] Liang, S., Deng, X.R., Chang, Y., et al. (2019) Intelligent Hollow Pt-CuS Janus Architecture for Synergistic Catalysis-Enhanced Sonodynamic and Photothermal Cancer Therapy. Nano Letters, 19, 4134-4145. [Google Scholar] [CrossRef] [PubMed]
[11] Min, H., Wang, J., Qi, Y.Q., et al. (2019) Biomimetic Metal-Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy. Advanced Materials, 31, E1808200. [Google Scholar] [CrossRef] [PubMed]
[12] Lin, L.-S., Huang, T., Song, J.B., et al. (2019) Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy. Journal of the American Chemical Society, 141, 9937-9945. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, Q., Chen, J.W., Yang, Z.J., et al. (2019) Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy. Advanced Materials, 31, E1802228. [Google Scholar] [CrossRef] [PubMed]
[14] Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
[15] Soerjomataram, I., Oomen, D., Lemmens, V., et al. (2010) Increased Consumption of Fruit and Vegetables and Future Cancer Incidence in Selected European Countries. European Journal of Cancer, 46, 2563-2580. [Google Scholar] [CrossRef] [PubMed]
[16] Matsumura, Y. and Maeda, H. (1986) A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs. Cancer Research, 46, 6387-6392.
[17] Fang, J., Sawa, T. and Maeda, H. (2003) Factors and Mechanism of “EPR” Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS. Advances in Experimental Medicine and Biology, 519, 29-49. [Google Scholar] [CrossRef
[18] Miller, M.A., Zheng, Y.-R., Gadde, S., et al. (2015) Tumour-Associated Macrophages Act as a Slow-Release Reservoir of Nano-Therapeutic Pt(IV) Pro-Drug. Nature Communications, 6, Article No. 8692. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Y.H., Zhao, Q.F., Zhao, B.Y., et al. (2022) Remodeling Tumor-Associated Neutrophils to Enhance Dendritic Cell-Based HCC Neoantigen Nano-Vaccine Efficiency. Advanced Science (Weinh), 9, E2105631. [Google Scholar] [CrossRef] [PubMed]
[20] Tian, H.L., Zhao, S., Nice, E.C., et al. (2022) A Cascaded Copper-Based Nanocatalyst by Modulating Glutathione and Cyclooxygenase-2 for Hepatocellular Carcinoma Therapy. Journal of Colloid and Interface Science, 607, 1516-1526. [Google Scholar] [CrossRef] [PubMed]